Traws Pharma
(NASDAQ) TRAW
Traws Pharma Financials at a Glance
Market Cap
$9.27M
Revenue (TTM)
$2.90M
Net Income (TTM)
$17.12M
EPS (TTM)
$1.37
P/E Ratio
0.85
Dividend
$0.00
Beta (Volatility)
1.03 (Average)
Dividend
$0.00
Beta (Volatility)
1.03 (Average)
Price
$1.14
Volume
323,642
Open
$1.24
Price
$1.14
Volume
323,642
Open
$1.24
Previous Close
$1.14
Daily Range
$1.12 - $1.25
52-Week Range
$0.97 - $3.27
Dividend
$0.00
Beta (Volatility)
1.03 (Average)
Price
$1.14
Volume
323,642
Open
$1.24
Previous Close
$1.14
Daily Range
$1.12 - $1.25
52-Week Range
$0.97 - $3.27
TRAW News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Traws Pharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
7
CEO
Iain David Dukes, PhD
Website
www.trawspharma.comHeadquarters
Newtown, PA 18940, US
TRAW Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-2%
Net Income Margin
-1%
Return on Equity
-248%
Return on Capital
10%
Return on Assets
-34%
Earnings Yield
1.18%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$9.27M
Shares Outstanding
7.99M
Volume
323.64K
Short Interest
0.00%
Avg. Volume
161.22K
Financials (TTM)
Gross Profit
$2.73M
Operating Income
$17.88M
EBITDA
$17.81M
Operating Cash Flow
$18.18M
Capital Expenditure
$2.58M
Free Cash Flow
$20.77M
Cash & ST Invst.
$3.82M
Total Debt
$0.00
Traws Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$57.00K
-49.6%
Gross Profit
$57.00K
-47.7%
Gross Margin
100.00%
N/A
Market Cap
$9.27M
N/A
Market Cap/Employee
$1.54M
N/A
Employees
6
N/A
Net Income
$3.04M
+66.0%
EBITDA
$4.04M
+56.4%
Quarterly Fundamentals
Net Cash
$3.82M
-81.7%
Accounts Receivable
$3.79M
+20977.8%
Inventory
$0.00
-100.0%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-34.47%
N/A
Return on Invested Capital
10.03%
N/A
Free Cash Flow
$14.79M
-233.9%
Operating Cash Flow
$12.21M
-175.5%